Trial intelligence / Profile preview

EGP-437 in non-infectious anterior segment uveitis

NCT00694135Phase 2Completed

Sponsor
Kiora Pharmaceuticals
Start
Jun 2008
Primary completion
Jul 2009
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of dexamethasone phosphate iontophoretic ophthalmic solution in anterior uveitis (AU), sponsored by Kiora Pharmaceuticals. Started Jun 2008; status: completed.

02

Drugs

dexamethasone phosphate iontophoretic ophthalmic solution
03

Conditions

anterior uveitis (AU)

Beyond the preview

Go deeper on NCT00694135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00694135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call